RNF126 Activators
Chemicals that can influence the activity of RNF126, an E3 ubiquitin-protein ligase, are diverse and affect different cellular processes. For instance, proteasome inhibitors like MG132, Epoxomicin, and Bortezomib can indirectly increase RNF126 activity by halting the degradation of proteins ubiquitinated by RNF126. This increases the effective ubiquitin ligase activity of RNF126. Compounds such as Nutlin-3 and PRIMA-1Met, which manipulate the p53 pathway, indirectly influence RNF126 activity. p53 can upregulate the expression of RNF126, so modulating p53 activity affects RNF126.
Chemicals like 5-Aza-2'-deoxycytidine and Trichostatin A, which inhibit DNA methylation and histone deacetylation respectively, can increase RNF126 expression by promoting a more relaxed chromatin state conducive to transcription. Finally, kinase inhibitors such as Genistein, Staurosporine, LY294002, Wortmannin, and U0126 can influence various signaling pathways that might regulate RNF126. Their effects can be indirect and complex due to the many roles of kinases in cellular signaling. These chemicals underscore the interconnectedness of cellular pathways and the potential for wide-ranging effects when one pathway is modified.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Similar to MG132, Epoxomicin is a proteasome inhibitor that can stop the degradation of proteins ubiquitinated by RNF126, indirectly increasing its activity. | ||||||
PRIMA-1MET | 5291-32-7 | sc-361295 sc-361295A | 10 mg 25 mg | $153.00 $325.00 | 5 | |
PRIMA-1^Met is a reactivator of mutant p53. Given that p53 can upregulate the expression of RNF126, PRIMA-1^Met can indirectly affect RNF126 activity. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2'-deoxycytidine is a DNA methylation inhibitor. Since DNA methylation can suppress gene expression, inhibiting this process can indirectly increase RNF126 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an inhibitor of Histone Deacetylase (HDAC). HDAC removes acetyl groups from histones, which can suppress gene expression. Inhibiting HDAC can indirectly increase RNF126 expression. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can affect multiple signaling pathways, potentially influencing RNF126 activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor that can affect multiple signaling pathways, potentially influencing RNF126 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. Given that PI3K signaling can potentially regulate RNF126, LY294002 can indirectly affect RNF126 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor. Since PI3K signaling can potentially regulate RNF126, Wortmannin can indirectly affect RNF126 activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor. Given that MEK is part of the MAPK/ERK pathway, which can potentially regulate RNF126, U0126 can indirectly affect RNF126 activity. | ||||||